Laser photocoagulation, intravitreal anti-VEGF, and vitreous surgery for the treatment of juxtapapillary retinal capillary hemangioma

Indian J Ophthalmol. 2019 Dec;67(12):2104-2106. doi: 10.4103/ijo.IJO_1799_18.

Abstract

Juxtapapillary retinal capillary hemangiomas (JRCHs) are benign vascular tumors located on or adjacent to the optic nerve head. A 19-year-old girl presented with epiretinal membrane (ERM) associated with an elevated and round vascular tumoral mass located in the juxtapapillary region of her left eye. She was subsequently diagnosed with isolated JRCH. A combined approach with laser photocoagulation and intravitreal bevacizumab injection was used to facilitate shrinkage of the tumor preoperatively and pars plana vitrectomy was used to remove the tumor and ERM. A small remnant of tumoral mass remained intact and did not show any growth for 7 years.

Keywords: Capillary hemangioma; epiretinal membrane; juxtapapillary; optic nerve; retina.

Publication types

  • Case Reports

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use*
  • Bevacizumab / therapeutic use*
  • Combined Modality Therapy
  • Epiretinal Membrane / drug therapy
  • Epiretinal Membrane / surgery
  • Epiretinal Membrane / therapy
  • Female
  • Hemangioma, Capillary / drug therapy
  • Hemangioma, Capillary / surgery
  • Hemangioma, Capillary / therapy*
  • Humans
  • Intravitreal Injections
  • Light Coagulation*
  • Retinal Neoplasms / drug therapy
  • Retinal Neoplasms / surgery
  • Retinal Neoplasms / therapy*
  • Tomography, Optical Coherence
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors
  • Vitrectomy*
  • Vitreous Body / surgery
  • Young Adult

Substances

  • Angiogenesis Inhibitors
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Bevacizumab